Craig C. Hopkinson - Sep 14, 2021 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Sep 14, 2021
Transactions value $
-$172,798
Form type
4
Date filed
9/16/2021, 04:25 PM
Previous filing
Jun 11, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Award $0 +15.1K $0.00 15.1K Sep 14, 2021 Direct F1
transaction ALKS Ordinary Shares Tax liability -$173K -5.65K -37.29% $30.60 9.5K Sep 14, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards ("PRSUs") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals.